Lack of a clinically relevant interaction between etanercept (E) & digoxin (D).

被引:0
|
作者
Patat, AA
Parks, V
Simcoe, DK
Korth-Bradley, JM
Le Coz, F
机构
[1] Wyeth Ayerst Res, Paris, France
[2] Wyeth Ayerst Res, Collegeville, PA USA
[3] Biotrial, Rennes, France
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:P64 / P64
页数:1
相关论文
共 50 条
  • [41] The clinically relevant interaction of warfarin and capecitabine
    Kessler, P.
    Poul, H.
    Harudova, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 824 - 824
  • [42] STIMULANTS - INTERACTION WITH CLINICALLY RELEVANT DRUGS
    ELLINWOOD, EH
    EIBERGEN, RD
    KILBEY, MM
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1976, 281 (DEC10) : 393 - 408
  • [43] FURTHER INSIGHTS INTO DIGOXIN-QUINIDINE INTERACTION - LACK OF CORRELATION BETWEEN SERUM DIGOXIN CONCENTRATION AND INOTROPIC STATE OF THE HEART
    HIRSH, PD
    WEINER, HJ
    NORTH, RL
    AMERICAN JOURNAL OF CARDIOLOGY, 1980, 46 (05): : 863 - 868
  • [44] Lack of a Clinically Relevant Effect of an Antacid on the Pharmacokinetics of Lersivirine
    Vourvahis, M.
    Banerjee, S.
    LaBadie, R.
    Gore, D.
    Mayer, H.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (05) : 2209 - 2211
  • [45] Lack of clinically significant interference by spironolactone with the AxSym digoxin II assay
    Howard, G
    Barclay, M
    Florkowski, C
    Moore, G
    Roche, A
    THERAPEUTIC DRUG MONITORING, 2003, 25 (01) : 112 - 113
  • [46] Pharmaceutical interaction - No clinically relevant interactions in Cyp2d6
    不详
    PSYCHOPHARMAKOTHERAPIE, 2007, 14 (04): : A12 - A13
  • [47] Clinically relevant bidirectional drug-drug interaction between midostaurin and voriconazole
    Haefliger, David
    Marzolini, Catia
    Lamoth, Frederic
    Pabst, Thomas
    Buclin, Thierry
    Livio, Francoise
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (07) : 2304 - 2308
  • [48] Mechanism of clinically relevant drug-drug interaction between cerivastatin and gemfibrozil
    Shitara, Y
    Hirano, M
    Sato, H
    Sugiyama, Y
    DRUG METABOLISM REVIEWS, 2004, 36 : 297 - 297
  • [49] IS THERE A CLINICALLY RELEVANT INTERACTION BETWEEN DIAZEPAM AND LIPOPHILIC BETA-BLOCKING DRUGS
    BETTS, TA
    CROWE, A
    KNIGHT, R
    RAFFLE, A
    PARSONS, A
    BLAKE, A
    HAWKSWORTH, G
    PETRIE, JC
    DRUGS, 1983, 25 : 279 - 280
  • [50] Absence of clinically relevant interaction between sugammadex and aspirin on platelet aggregation and coagulation
    Kruithof, A.
    De Kam, P. J.
    El Galta, R.
    Burggraaf, J.
    Kluft, C.
    Fennema, H.
    Van Lierop, M. J.
    Mihara, K.
    Jagt-Smook, M.
    Moerland, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1141 - 1142